USPTO serial 97383618
CANTATA BIO
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RENNEKER, CHRISTOPHER JOHN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CANTATA BIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Scotts Valley, CA, US
Scotts Valley, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kelly L. Williams
Kelly L. Williams QUARLES & BRADY LLP2020 K Street, NW, Suite 400WASHINGTON, DC 20006-1806United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical test kits for use in gene analysis and sequencing as well as DNA analysis and sequencing for laboratory or research use; kits comprised of assays and reagents for use in gene analysis and sequencing as well as DNA analysis and sequencing for scientific research use | ACTIVE | — |
| 005 | Kits comprised of chemical reagents and enzymes for use in gene analysis and sequencing as well as DNA analysis and sequencing for medical use | ACTIVE | — |
| 009 | Kits comprised primarily of test tubes, medical sample tubes, vials, boxes, containers, syringes, and petri dishes, for use in collection, storage and preparation of materials for gene analysis and sequencing as well as DNA analysis and sequencing for laboratory use | ACTIVE | — |
| 010 | Kits comprised primarily of medical sample tubes and vials, boxes, containers, syringes, and petri dishes, for use in collection, storage and preparation of blood and other bodily fluids and materials for use in medical gene analysis and sequencing as well as DNA analysis and sequencing for use in the diagnosis and treatment of medical conditions | ACTIVE | — |
| 042 | Scientific research services, namely, gene analysis and sequencing as well as DNA analysis and sequencing; scientific research services, namely, preparation of materials for gene analysis and sequencing as well as DNA analysis and sequencing; providing temporary use of non-downloadable software for use in gene analysis and sequencing as well as DNA analysis and sequencing | ACTIVE | — |
| 044 | Gene analysis and sequencing as well as DNA analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing as well as DNA analysis and sequencing for use in cancer diagnosis and treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Arc Bio, LLC
- Other trademarks owned by Arc Bio, LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CANTATA BIO
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 5, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 2, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 1, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 1, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 19, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 25, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 25, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 25, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 21, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 20, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 20, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 20, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 3, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 3, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 3, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 3, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 2, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 1, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 1, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 5, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 11, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 11, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 21, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 4, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 2, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 8, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 28, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 15, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 15, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 15, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 15, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 15, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 15, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2022 | NWAP | NEW APPLICATION ENTERED | — |